Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating. Benzinga · Jul 1, 2025
Health care startups turn to ‘coaches’ to help patients cope and monitor treatment In 2011, Sean Duffy and Adrian James were sitting in San Francisco’s Dolores Park debating what to call some workers at the company they founded, Omada Health. Tribune News Service · Jun 29, 2022